Victory Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Buy |
80,123
+7,308
| +10% | +$1M | 0.01% | 1079 |
|
|
2025
Q1 | $13.1M | Sell |
72,815
-8,513
| -10% | -$1.53M | 0.01% | 952 |
|
|
2024
Q4 | $12.7M | Sell |
81,328
-16,957
| -17% | -$2.66M | 0.01% | 996 |
|
|
2024
Q3 | $17.9M | Sell |
98,285
-45,580
| -32% | -$8.3M | 0.02% | 887 |
|
|
2024
Q2 | $26.4M | Buy |
143,865
+9,045
| +7% | +$1.66M | 0.03% | 706 |
|
|
2024
Q1 | $24M | Sell |
134,820
-38,059
| -22% | -$6.77M | 0.02% | 748 |
|
|
2023
Q4 | $21.4M | Sell |
172,879
-36,608
| -17% | -$4.54M | 0.02% | 751 |
|
|
2023
Q3 | $24.3M | Buy |
209,487
+12,448
| +6% | +$1.44M | 0.03% | 671 |
|
|
2023
Q2 | $23.1M | Sell |
197,039
-15,091
| -7% | -$1.77M | 0.03% | 717 |
|
|
2023
Q1 | $17M | Sell |
212,130
-127,201
| -37% | -$10.2M | 0.02% | 845 |
|
|
2022
Q4 | $26.9M | Buy |
339,331
+35,732
| +12% | +$2.83M | 0.03% | 668 |
|
|
2022
Q3 | $21.2M | Buy |
303,599
+276,251
| +1,010% | +$19.3M | 0.02% | 784 |
|
|
2022
Q2 | $1.8M | Buy |
+27,348
| New | +$1.8M | ﹤0.01% | 1504 |
|
|
2022
Q1 | – | Sell |
-2,864
| Closed | -$200K | – | 2771 |
|
|
2021
Q4 | $200K | Buy |
+2,864
| New | +$200K | ﹤0.01% | 2486 |
|
|
2021
Q2 | – | Sell |
-2,776
| Closed | -$214K | – | 2790 |
|
|
2021
Q1 | $214K | Buy |
+2,776
| New | +$214K | ﹤0.01% | 2512 |
|
|
2020
Q4 | – | Sell |
-524,144
| Closed | -$22.6M | – | 2564 |
|
|
2020
Q3 | $22.6M | Buy |
524,144
+246,047
| +88% | +$10.6M | 0.03% | 739 |
|
|
2020
Q2 | $11.5M | Buy |
278,097
+274,919
| +8,651% | +$11.4M | 0.02% | 978 |
|
|
2020
Q1 | $138K | Buy |
3,178
+1,074
| +51% | +$46.6K | ﹤0.01% | 2436 |
|
|
2019
Q4 | $117K | Buy |
2,104
+365
| +21% | +$20.3K | ﹤0.01% | 2491 |
|
|
2019
Q3 | $60K | Buy |
+1,739
| New | +$60K | ﹤0.01% | 2603 |
|